Education
About Us
Working with TipRanks
Follow Us
KP Tissue (TSE:KPT)
:KPT
Total Valuation
KP Tissue has a market cap or net worth of C$79.65M. The enterprise value is C$82.19M.
Market CapC$79.65M
Enterprise ValueC$82.19M
Share Statistics
KP Tissue has 9,994,203 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,994,203
Owned by Insiders0.49%
Owned by Institutions2.42%
Financial Efficiency
KP Tissue’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-0.07
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee-1.83K
Employee Count2,700
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of KP Tissue is -18.19. KP Tissue’s PEG ratio is 0.35.
PE Ratio-18.19
PS Ratio―
PB Ratio1.31
Price to Fair Value1.31
Price to FCF12.86
Price to Operating Cash Flow12.86
PEG Ratio0.35
Income Statement
In the last 12 months, KP Tissue had revenue of 0.00 and earned -4.94M in profits. Earnings per share was -0.50.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income-830.00K
Net Income-4.94M
EBITDA238.61M
Earnings Per Share (EPS)-0.50
Cash Flow
In the last 12 months, operating cash flow was 3.50M and capital expenditures 0.00, giving a free cash flow of 3.50M billion.
Operating Cash Flow3.50M
Free Cash Flow3.50M
Free Cash Flow per Share0.35
Dividends & Yields
KP Tissue pays an annual dividend of C$0.72, resulting in a dividend yield of 9.03%
Dividend Per ShareC$0.72
Dividend Yield9.03%
Payout Ratio63.21%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.18
52-Week Price Change5.15%
50-Day Moving Average7.82
200-Day Moving Average7.89
Relative Strength Index (RSI)54.64
Average Volume (3m)12.67K
Important Dates
KP Tissue upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateMar 5, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend DateMar 31, 2025
Financial Position
KP Tissue as a current ratio of 1.09, with Debt / Equity ratio of 0.00%
Current Ratio1.09
Quick Ratio1.09
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, KP Tissue has paid 4.11M in taxes.
Income Tax4.11M
Effective Tax Rate-4.95
Enterprise Valuation
KP Tissue EV to EBITDA ratio is 0.38, with an EV/FCF ratio of 12.86.
EV to Sales0.00
EV to EBITDA0.38
EV to Free Cash Flow12.86
EV to Operating Cash Flow12.86
Balance Sheet
KP Tissue has C$0.00 in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$0.00 billion.
Cash & Marketable SecuritiesC$0.00
Total DebtC$0.00
Net CashC$0.00
Net Cash Per ShareC$0.00
Tangible Book Value Per ShareC$6.87
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for KP Tissue is C$8.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetC$8.50
Price Target Upside6.65% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―